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Abstract
Background: Dementia is a major public health problem with enormous costs to society and
major consequences for both patients and their relatives. Family members of persons with
dementia provide much of the care for older adults with dementia in the community. Caring for a
demented relative is not easy and fraught with emotional strain, distress, and physical exhaustion.
Family caregivers of dementia patients have an extremely high risk developing affective disorders
such as major depression and anxiety disorder. Family meetings appear to be among the most
powerful psychosocial interventions to reduce depression in caregivers.
An American landmark study reported substantial beneficial effects of a multifaceted intervention
where family meetings had a central place on depression in family caregivers as well as on delay of
institutionalization of patients. These effects were not replicated in other countries yet. We
perform the first trial comparing only structured family meetings with significant others versus
usual care among primary family caregivers of community dwelling demented patients and measure
the effectiveness on both depression and anxiety in the primary caregiver, both on disorder and
symptom levels.
Methods/design: In this randomized controlled trial effectiveness as well as cost-effectiveness of
family meetings is evaluated. The intervention group receives four family meetings with family and
close friends of the primary family caregiver of a community dwelling patient with a clinical diagnosis
of dementia. Dyads of patients and their primary caregiver are followed up to one year after
baseline assessment. The main outcome measures are the incidence of anxiety and depressive
disorders assessed with the Mini-International Neuropsychiatric Interview (MINI) and the severity
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the Centre for Epidemiologic Studies Depression Scale (CES-D) for depression and the anxiety
scales of the Hospital Anxiety and Depression scales (HADS) for anxiety. The economic evaluation
is performed from a societal perspective.
Discussion: By evaluating the effectiveness of only structured family meetings organized in the
Netherlands, this study will contribute to the existing literature about the value of psychosocial
interventions for dementia caregivers.
Trial registration: Dutch Trial Registry ISRCTN90163486
Background
Dementia is a major public health problem. The esti-
mated prevalence rate of dementia among community
dwelling elderly aged 65 to 95 is 6.6% [1]. A recent paper
reported that approximately 5.1 million people in the
European Union live with dementia. Within the next 50
years this number will rise to approximately 11.9 million
cases [2]. Because most people with dementia have a sup-
porter or caregiver the number of family caregivers caring
for a demented person will increase substantially as well.
Dementia is a syndrome with major consequences for
both patients and their relatives. Caring for a demented
relative is not easy and fraught with emotional strain, dis-
tress, and physical exhaustion. Previous studies showed
the negative psychological, physical and social conse-
quences associated with providing care to a relative with
AD [4-6].
Family caregivers of dementia patients have an extremely
high risk developing affective disorders such as major
depression and anxiety disorder [3,7]. The month preva-
lence of depressive disorders among caregivers varied
between 15–32% in three representative community sam-
ples, the 12 months incidence of depressive disorders was
48% as reported in one representative sample [7,8]. Data
on anxiety disorders in dementia caregivers are scarce but
suggest that 1 in 3 caregivers suffers from an anxiety disor-
der [9]. Depressive and anxiety symptoms are even more
prevalent and affect between half to three-quarter of all
caregivers [7,8,10]. The risk to develop an affective disor-
der persists over many years of caregiving and even after
caregiving ends with the death of a care recipient [3,11].
Despite a wide range of useful services that can help
patients and relief caregivers, the burden of caregiving
remains very high [3]. Long term institutionalization of
demented patients is extremely costly. The mental health
of the family caregiver is often decisive in the timing of
nursing home placement. Any intervention that can relief
the burden of caregiving and (thereby) prevent mental
health problems of caregivers is important. In addition, if
such efforts can delay nursing home placement they are
likely to be extremely cost-effective.
Despite dementia caregivers often providing intensive lev-
els of assistance and reporting low levels of life satisfac-
tion and high levels of overload, their use of support
services is low. Perceived lack of need or lack of awareness
are the main reasons for this non-use of services [12]. An
empowering intervention like family meetings seems to
connect very well by the demand of many caregivers to
solve things on their own.
Moreover, psycho-education, an essential component of
the family meetings, shows consistent effects on various
outcomes like caregiver burden, depression and subjective
well-being [13]. The involvement of other family mem-
bers in the intervention may in all probability strengthen
these positive effects.
Our hypothesis is that affective disorders of dementia car-
egivers are largely preventable. Systematic reviews and
meta-analyses show that information and support alone
is helpful but only address the psychological needs of car-
egivers modestly at best [13,14]. Programs that demon-
strate beneficial effects on affective disorders involved
both patients and their families, are more intensive and
modified to caregivers needs [14,15]. As demonstrated in
the landmark studies of Mittelman et al., family meetings,
designed to mobilize support of naturally existing family
networks, appear to be among the most powerful psycho-
social interventions to reduce depression in caregivers
[16-19]. However, no studies have evaluated the preven-
tive effects on anxiety. Family counseling can maximize
the positive contributions of each member to caregiving,
prevent one member from carrying the entire weight of
the caregiving role, improve the caregiver's understanding
of how to ask for help, what kind of help is reasonable to
expect from family members, and how to accept help, and
reduce family conflict. In addition, these programs
resulted in postponement of nursing home placement of
patients [17,20].Page 2 of 9
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seling component of this intervention has not been tested.
Furthermore, effects of family meetings were not repli-
cated in other countries yet. Therefore, inspired by the
New York University Spouse-Caregiver Intervention
Study, the Department of General Practice of the VU Med-
ical Center developed an innovative intervention to sup-
port primary family caregivers of a community dwelling
patient with a clinical diagnosis of dementia.
Four meetings with family and close friends will be organ-
ized and run by a trained counsellor according to a man-
ual [21] and additional information from in depth
interviews with the original counselors. The aim is to offer
psycho-education, increase problem solving skills and
mobilize the naturally existing social network of patient
by sharing support tasks of network members. A rand-
omized controlled trial is performed to investigate the
effectiveness and cost-effectiveness of family meetings on
indicated prevention of anxiety and depressive disorders
and symptom levels of primary family caregivers of
patients with dementia.
By evaluating the effectiveness of only structured family
meetings organized in the Netherlands, this study will
contribute to the existing literature about the value of psy-
chosocial interventions for dementia caregivers. In addi-
tion, this study involves some other innovative elements.
The New York University Spouse-Caregiver Intervention
[22] was done with spouse caregivers of Alzheimer type
dementia patients only and measured effects on depres-
sion but not on anxiety. In our study we also include other
caregivers relations (e.g. child, brother/sister), but this car-
egiver has to live together with the patient. We expect this
group to be particularly burdened and therefore vulnera-
ble to develop a depression or anxiety disorder. Further-
more, we include also patients with non-alzheimer type
dementias and measure both depression and anxiety in
the caregiver.
The objective of this paper is to describe the study proto-
col of this RCT among primary family caregivers of
dementia patients. The main research questions concern
whether structured family meetings are more (cost)-effec-
tive than usual care in preventing caregivers of depression
or anxiety disorders, decreasing severity of symptoms and
caregiver burden, increasing caregiver's and patient's qual-
ity of life, and in increasing days until institutionalization.
Methods/design
Design
The design is a randomized controlled indicated preven-
tion trial (Figure 1). After selection, and baseline assess-
ment, dyads of patients and their primary family caregiver
are randomized to one of two groups; the intervention
group receives usual care plus family meetings, the control
group receives usual care only. Participants are free to seek
additional assistance and support elsewhere at any time
throughout 12 months follow-up. Participants are only
allowed to enter the study after signed informed consent.
In case of mental incompetence of a patient the family car-
egiver will sign the consent for the patient. The Medical
Ethics Committee of the VU University medical centre in
Amsterdam has approved the study (ref. no 2007/83). The
study is registered as clinical trial under
ISRCTN90163486.
Participants
Caregivers and patients are recruited through various
memory clinics and specialized mental health care institu-
tions. Caregivers are potentially eligible if they are a pri-
mary caregiver of a non-institutionalized relative with a
clinical diagnosis of dementia and lives in the same region
as the patient. In each family, at least one other family
member lives in the same region of the patient and car-
egiver. If the dementia patient has more than one family
caregiver, the primary caregiver is the one who coordi-
nates the caring process, mostly the person who spends
the most hours on caregiver tasks. We only include
spouses, children (-in-law) and brothers/sisters living
with the patient.
Patients and caregivers will be excluded when having
severe somatic or psychiatric co-morbidity which will sig-
nificantly impair cooperation to the program. Because the
aim is to prevent caregivers for developing an anxiety or
depressive disorder the incidence of anxiety and depres-
Flowchart of study designigure 1
Flowchart of study design.
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to exclude caregivers who already have a depressive or
anxiety disorder. To detect prevalent cases caregivers are
screened before baseline assessment with the MINI. They
will also be excluded when either caregiver or patient par-
ticipates in other intervention studies at inclusion or dur-
ing the study. The in- and exclusion criteria are listed in
Table 1.
Randomization
Randomization takes place after baseline measurement.
An external person independent from our study group
establishes the random order using random number
tables. Blocking by center is used to ensure that compari-
son groups are of approximately the same size per center.
Intervention
Primary caregivers in the intervention group will partici-
pate in four meetings with family and close friends which
will be organized and run by a counselor with an
advanced degree in nursing, social work, psychology or
allied professions. The four family counseling sessions
will follow the manual inspired by the New York Univer-
sity Spouse-Caregiver Intervention Study [21] and addi-
tional information from in depth interviews with the
original counselors. This information clarifies and illus-
trates the basis principles of the intervention. Counselors
have received a training prior to the study. One counselor
is assigned to one caregiver to establish an ongoing rela-
tionship with someone who is familiar with the situation.
Every site will pilot some meetings before the effect study
will start. The aims of the family meetings are: 1) to edu-
cate families about dementia consequences and resource
information for care support; 2) to mobilize naturally
existing family networks of patient and primary caregiver
in order to improve emotional and instrumental support;
3) to teach problem solving and techniques for trouble-
some patient behavior that can be used after family coun-
seling ends. The content of the sessions is also determined
by the needs of each caregiver. For example, learning tech-
niques, for management of troublesome behavior, pro-
moting communication between family members. All
sessions are audio taped for supervision, intervision and
detailed analysis. Besides, for every meeting the counselor
fills in a standardized report for process evaluation.
Usual care
The diagnostic assessments at memory clinics in the Neth-
erlands lead to a disclosure meeting with the patient and
in most cases the primary family caregiver. Patients diag-
nosed with dementia and their accompanying family
members are informed about the facilities that can help
caring for the patients. Helpful leaflets, addresses, phone
number and web sites are provided. Next, most patients
are referred back to their General Practitioner. About a
quarter of Alzheimer patients is prescribed anti-Alzheimer
medication, and in such cases patient and family caregiver
visit the memory clinic regularly for medication control
visits. Family meetings are organized rarely and never in a
structured way and with follow-ups. Moreover they tend
to focus on providing clinical information and not on
increasing family support.
In contrast with memory clinics, most mental health care
institutions do offer support for caregivers of dementia
patients. The kind of support differs per institution. This
varies from support groups for caregivers to case manage-
ment for active support and organization of needed care.
Just like memory clinics, mental health care institutions
rarely organize family meetings and never in a structured
way and with follow-ups.
Measurements
Table 2 provides an overview of all effect and economic
measurements. Before baseline, caregivers will be
screened on the presence of a depressive or anxiety disor-
der. This measurement is repeated every 3 months (at T1,
T2, T3 and T4). At baseline (T0) and after 6 (T2), 12 (T4)
months participants are interviewed by trained interview-
ers. The interviewers leave cost diaries for caregiver and
patient to register medical consumption. When patients
are unable to answer the questions their informal car-
egiver is allowed to answer or to provide assistance.
Effect evaluation
Primary outcomes are:
Table 1: Inclusion and exclusion criteria
Inclusion criteria
▪ Family caregiver:
- takes primary responsibility for the family care of a community 
dwelling patient with a clinical diagnosis of dementia
- is spouse, child (-in-law) or brother or sisters of the patient.
- lives together with the patient
▪ In each family, at least one other family member or close friend lives 
in the same region of the patient and caregiver.
▪ Both caregiver and patient have sufficient language proficiency in 
Dutch for adequate participation in meetings, interviews and tests.
Exclusion criteria
▪ Severe somatic or psychiatric co-morbidity of either caregiver or 
patient, which will significantly impair cooperation to the program.
▪ Caregiver has a depression or anxiety disorder at baseline
▪ Either caregiver or patient participates in other intervention studies 
at inclusion or during the study which may interfere substantially with 
the study outcomes.
▪ The patient is scheduled to move a nursing home in short notice.Page 4 of 9
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(generalised anxiety, panic, social phobia, agoraphobia,
obsessive compulsive disorder, hypochondria) as defined
according to DSM-IV criteria [23] and assessed with the
Mini International Neuropsychiatric Interview (MINI)
[24]. The MINI is used as 3 month prevalence measure.
2. The severity of anxiety and depression symptoms in car-
ers is measured by validated self report instruments. For
depression we use the Centre for Epidemiologic Studies
Depression Scale (CES-D) [25]. For anxiety, the anxiety
scale from the Hospital Anxiety and Depression Scales
(HADS) [26,27] is used.
Secondary outcomes are:
3. Caregiver burden with the Short Sense of Competence
Questionnaire (SSCQ) [28], the Caregiver Reaction
Assessment (CRA) [29] and a single self-rated burden
question (SRB) [30].
4. Caregiver's quality of life with the Short Form 12 item
version[31,32].
5. Social support caregiver (see below)
6. Days until institutionalization of the patient
One of the main goals of the intervention is to mobilize
support of naturally existing family networks. Therefore
social support of caregiver is measured with a Social Sup-
port Assessment based on the Caregiver Assessment Bat-
tery used in the studies of Mittelman [20]. In this
assessment the caregiver is asked how satisfied he/she is
with his or her social network in general, if he/she is satis-
fied with the received amount of emotional and practical
support and if this received support is useful. In addition,
loneliness is measured with the loneliness scale [33].
Potential effect modifiers
Besides the primary and secondary outcomes, we evaluate
several variables which we assume as potential effect
modifiers. The following variables on the level of the car-
egiver are assessed: socio-demographic characteristics,
characteristics of the caregiving situation (family relation
between patient and caregiver, duration and hours of car-
egiving, type of caregiving), presence of chronic diseases.
On patient level we assess socio-demographic characteris-
tics, cognitive functioning with the MMSE [34], type of
dementia, depressive and behavioral symptoms with the
Neuropsychiatric Inventory (NPI)[35], patient's quality of
life as measured with the SF-12, (Instrumental) Activities
of daily living [36,37], medical co-morbidity and treat-
ment and formal care support.
Additional measures
In order to take note of the kind of problems dementia
caregivers have to deal with, we used the Psychological
Outcomes Profiles (PSYCHLOPS). This is a practical sim-
ple tool that focuses on problems respondents experience.
With the PSYCHLOPS we evaluate if problems of caregiv-
ers disappear during the intervention or are substituted by
other problems.
Besides the CES-D to measure depressive symptoms in
caregivers, we added the Geriatric Depression Scale (GDS-
5) [38] to be able to integrate data with the intervention
study of Mittelman.
Table 2: Measurement Scheme
Variable Instrument T-1 T0 T1 T2 T3 T4
Effect evaluation: primary outcomes
Depressive & anxiety disorders MINI X X X X X
Severity depression CES-D, GDS-5 X X X
Severity anxiety HADS anxiety subscale X X X
Effect evaluation: secondary outcomes
Quality of life caregiver SF-12 X X X
Caregiver burden SSCQ, CRA, SRB X X X
Social support in caregiver Questions based on assessment battery study X X X
Days until institutionalisation patient according to carer Continuous registration
Economic evaluation
Direct and indirect costs carer + patient Cost diaries X X X
T0 = baseline
T1 = 3 months after baseline
T2 = 6 months after baseline
T3 = 9 months after baseline
T4 = 12 months after baselinePage 5 of 9
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A process evaluation will be included to help interpret the
outcome results. Furthermore, this process evaluation has
the following aims:
- to document how the intervention is implemented and
to what extent the counselors adhered to the protocol.
Because of the flexible character of the intervention it is
important to record what really happened during the fam-
ily meetings.
- to examine the views of participating caregivers and
counselors on the intervention.
- to distinguish between key components of the interven-
tion. This can make clear through which mechanisms the
intervention may work and which components of the
intervention influence the study outcomes most.
We use several methods to collect process data:
- counselors complete a standard form after every session.
This form asks for the session characteristics (duration,
number of persons attending the meeting, attendance of
the patient) and content of the session (which problems
have been discussed, goals for the next session). After the
first and last session the counselor also provides some
background information about the family (level of
knowledge, family conflicts) and successfulness of the
intervention for the family according to the counselor.
- we check if every family in the intervention group
received the planned number of four sessions and if not,
the primary caregiver or counselor is asked for the reason.
- after the last session caregivers as well as counselors are
interviewed to explore their opinions on the intervention.
- all sessions are recorded to be able to evaluate other
aspects.
Economic evaluation
Six monthly cost diaries collect cost data from a societal
perspective. The evaluation is a combination of a cost-
effectiveness analysis on caregiver's depression and anxi-
ety and cost-utility analysis on caregivers and patients sep-
arately. Health-related utilities and in consequence
quality-adjusted life-years (QALYs) were measured using
the SF-6D, which is calculated using a sub-set of questions
from the SF-12[39]. If patients are not capable to answer
the questions their caregiver will rate the patients' health
on the SF-12.
The following costs of both caregiver and patient will be
considered: 1) direct healthcare costs, such as costs of the
family meetings, consultations of the general practitioner,
nursing home physician, medical specialist, hospitaliza-
tions, and medical department of the nursing home, and
use of medication and medical aids; 2) direct non-health-
care costs (travel time and costs, informal care time); 3)
indirect costs (costs of lost labour days of working caregiv-
ers). If available, Dutch guideline prices are used to value
resource use [40]. Otherwise, tariffs are used. A cost price
for the family meetings will be calculated using a bottom-
up approach. Medication costs are valued using prices of
the Royal Dutch Society for Pharmacy (Z-index 2004).
Lost productivity costs are calculated according to the fric-
tion cost approach (friction period 154 days) using the
mean age and sex specific income of the Dutch popula-
tion [41,42].
Sample size calculations
Sample size calculations are based on the expected effects
of the intervention on the main outcome measures, inci-
dence of affective disorders and increasing time to inci-
dent problems. Incidence estimates are derived from the
literature and other studies performed by our group (Pre-
vention of anxiety and depression in late life). Effect esti-
mates are based on the primary studies of Mittelman
[17,19]. We estimate the yearly incidence of affective dis-
orders among caregiver at risk conservatively at 30% [7].
We aim to reduce the incidence to 10% of new cases a
year. With an alpha of 0.05, power of 80%, 73 persons per
group are then needed. Assuming 15% loss to follow up
we need to recruit 2 × 73 × 100/85 = 172 pairs of dementia
patients and family caregivers. This number will be suffi-
cient as well to measure a moderately strong reduction
(Cohen's D > 0.5) in number of depressive or anxiety
symptoms.
Blinding
Baseline and follow up data are gathered by independent
and blinded interviewers. Participants are not blinded.
Analysis
Effect evaluation
Data will be primarily analyzed according to the Intention
to treat principle, i.e. including all participants with valid
data, regardless of whether they did or did not receive the
intervention. Subsequently, the results of the intention to
treat analysis will be compared with the results of the 'on
treatment' analysis, to assess whether protocol violations
have caused bias. Participants with documented devia-
tions from the protocol (i.e. participants who did not
receive the entire intervention or participants in either the
intervention or the control group with incomplete follow-
up data) will be excluded from the on treatment analysis.
Comparability between the intervention and usual care
groups will be assessed at baseline to check differences.Page 6 of 9
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(Cox Proportional Models) for the time to incident affec-
tive disorder and repeated measurement analyses for
number of symptoms. Both techniques can adjust for pos-
sible baseline imbalance, and potential modifiers (e.g.
dementia type and severity, gender caregiver, relation with
patient, patient centre/counselor, family type (e.g. conflic-
tions versus harmonious, close versus distant). Dropout
and loss to follow up will be described.
Economic evaluation
To compare costs between the two groups, confidence
intervals for the differences in mean costs are calculated
using bias-corrected and accelerated bootstrapping with
2000 replications [43]. For the cost-effectiveness analysis
the difference in total costs between the intervention and
usual care group are compared with the difference in psy-
chological problems and for the cost-utility analysis with
the difference in the number of QALYs gained after 24
months. Uncertainty around the cost-effectiveness and
cost-utility ratios will be calculated using bias-corrected
percentile bootstrapping method with 5000 replications
[44]. The bootstrapped cost-effect pairs will be plotted on
cost-effectiveness planes and will be used to calculate cost-
effectiveness acceptability curves.
Discussion
In this paper we described the study protocol of an inno-
vative RCT that evaluates (cost)-effectiveness of family
meetings on indicated prevention of anxiety and depres-
sive disorders and symptom levels of primary informal
caregivers of dementia patients who live at home.
A multi-component intervention including family meet-
ings led to sustained benefits in reducing depressive
symptoms in caregivers as well as in postponement of
nursing home placement of Alzheimer's disease patients
{Mittelman, 2004 135/id}{Mittelman, 2006 133/id}.
However, the effectiveness of using only the family coun-
seling component of this intervention has not been tested.
Furthermore, effects of family meetings were not repli-
cated in other countries yet. By evaluating the effective-
ness of only structured family meetings organized in the
Netherlands, this study will contribute to the existing lit-
erature about the value of psychosocial interventions for
dementia caregivers. In addition, this study involves some
other innovative elements. The New York University
Spouse-Caregiver Intervention {Mittelman, 2003 70/id}
was done with caregivers of Alzheimer type dementia
patients only and measured effects on depression but not
on anxiety. In our study we also include non-Alzheimer
type dementias and measure both depression and anxiety.
Besides these innovating elements which are a particular
strength of this study, we can also think of some limita-
tions or potential threats.
Selection of participants might be a possible limitation of
the study, because we only include patients living together
with a family caregiver and another supporting person in
their social network. This has consequences for the gener-
alizability of the results to other kind of situations, for
example patients living alone and having a child who
takes primary responsibility. It is also possible that coun-
selors instinctively exclude some kind of families, for
example because they think families are not suitable or
expect that they are not willing to participate.
A possible threat to achieve sufficient contrast exists when
(unstructured) family counseling will become part of the
usual care in some participating centers. So far, only in
some centers disclosure meetings are organized with fam-
ily members. In the recruitment phase, we will pay specific
attention to this to be sure that participating centers will
not yet organize family meetings in a frequent and struc-
tured way.
Because of our widely formulated inclusion criteria, and
limited exclusion criteria we expect heterogeneity in study
subjects. For example, it is likely that caregiving intensity
and ditto stress is differently for caregivers of patients in
the beginning of the dementia than for caregivers of
patients who are already in an advanced stadium. It is also
possible that the different types of dementia influences
the caregiving situation. This may substantially modify
the outcomes. Therefore it is important to include enough
study subjects and carry out an active recruitment of cent-
ers for participation in the study.
The Alzheimer Center of the VUmc has currently begun to
pilot family meetings. The first experiences with families
of recently diagnosed patients were very encouraging.
When effective, family meetings can be an important
addition to the current care services in the Netherlands.
The results of this study will be available in the beginning
of 2011.
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